Specific isoforms of translation initiation factor 4GI show differences in translational activity by Coldwell, Mark J & Morley, Simon J
  Published Ahead of Print 18 September 2006. 
10.1128/MCB.01248-06. 
2006, 26(22):8448. DOI:Mol. Cell. Biol. 
Mark J. Coldwell and Simon J. Morley
 
Translational Activity
Factor 4GI Show Differences in 
Specific Isoforms of Translation Initiation
http://mcb.asm.org/content/26/22/8448
Updated information and services can be found at: 
These include:
SUPPLEMENTAL MATERIAL
 Supplemental material
REFERENCES
http://mcb.asm.org/content/26/22/8448#ref-list-1at: 
This article cites 50 articles, 34 of which can be accessed free
CONTENT ALERTS
 more»articles cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new
http://journals.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 
http://journals.asm.org/site/subscriptions/To subscribe to to another ASM Journal go to: 
 o
n
 June 19, 2014 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
 o
n
 June 19, 2014 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
MOLECULAR AND CELLULAR BIOLOGY, Nov. 2006, p. 8448–8460 Vol. 26, No. 22
0270-7306/06/$08.000 doi:10.1128/MCB.01248-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Specific Isoforms of Translation Initiation Factor 4GI Show
Differences in Translational Activity†
Mark J. Coldwell and Simon J. Morley*
Department of Biochemistry, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QG, United Kingdom
Received 10 July 2006/Returned for modification 1 August 2006/Accepted 1 September 2006
The eukaryotic initiation factor (eIF) 4GI gene locus (eIF4GI) contains three identified promoters, gener-
ating alternately spliced mRNAs, yielding a total of five eIF4GI protein isoforms. Although eIF4GI plays a
critical role in mRNA recruitment to the ribosomes, little is known about the functions of the different isoforms,
their partner binding capacities, or the role of the homolog, eIF4GII, in translation initiation. To directly
address this, we have used short interfering RNAs (siRNAs) expressed from DNA vectors to silence the
expression of eIF4GI in HeLa cells. Here we show that reduced levels of specific mRNA and eIF4GI isoforms
in HeLa cells promoted aberrant morphology and a partial inhibition of translation. The latter reflected
dephosphorylation of 4E-BP1 and decreased eIF4F complex levels, with no change in eIF2 phosphorylation.
Expression of siRNA-resistant Myc-tagged eIF4GI isoforms has allowed us to show that the different isoforms
exhibit significant differences in their ability to restore translation rates. Here we quantify the efficiency of
eIF4GI promoter usage in mammalian cells and demonstrate that even though the longest isoform of eIF4GI
(eIF4GIf) was relatively poorly expressed when reintroduced, it was more efficient at promoting the translation
of cellular mRNAs than the more highly expressed shorter isoforms used in previous functional studies.
Translational control plays a critical role in overall gene
expression, allowing the rapid and reversible stimulation of pro-
tein synthesis from preexisting mRNAs, the fine-tuning of protein
expression levels, and in some cases the production of proteins at
specific sites in the cell (reviewed in reference 37). Eukaryotic
protein synthesis comprises three stages: initiation, elongation,
and termination. The initiation phase refers to the binding of
the ribosomal subunits to the mRNA and positioning of the
subunits at the first codon of the mRNA open reading frame.
Several eukaryotic initiation factors (eIFs) are required for this
process, and in most cases, initiation determines both the rate
of translation of individual mRNAs and the overall rate of
protein synthesis (17, 19, 32, 36). The inappropriate expression
of several initiation factors has been noted for a number of
diseases and cancers (1, 34), and the improper recruitment of
mRNAs to the ribosome may also play a role in the deregula-
tion of gene expression.
The multidomain factor eIF4G, expressed as two isoforms in
mammalian cells sharing 46% identity at the amino acid level
(eIF4GI/II), plays an essential role in mRNA recruitment by
acting as a molecular focal point upon which the translation
initiation complex is assembled to bring together the mRNA
and the ribosome. eIF4G is part of the eIF4F complex (17, 36),
which also comprises the mRNA cap-binding protein (eIF4E)
and an ATP-dependent RNA helicase activity (eIF4A, in con-
cert with eIF4B). The yeast, wheat, and mammalian homologs
bind to RNA in a sequence-independent manner (6, 28, 30),
although mammalian eIF4G also binds specifically to the 5
untranscribed region of the encephalomyocarditis virus RNA
genome, which contains an internal ribosome entry segment
(IRES) (30, 41). Interaction of the poly(A) binding protein
(PABP) with the N terminus of eIF4G (23), the kinase that
phosphorylates eIF4E (Mnk1) with the C terminus of eIF4G
(45) and the multisubunit eIF3 (and therefore the 40S ribo-
somal subunit and eIF2-GTP-initiator methionyl tRNA com-
plex) with the central portion of eIF4G, completes the forma-
tion of the 48S preinitiation complex (17, 37).
Consistent with an important regulatory role, the expression
level of eIF4G is low in both mammalian and yeast cells, and
its down-regulation by proteolysis is an early response to the
induction of apoptosis or infection by some viruses (reviewed
in reference 37). The importance of regulating the level of
expression of eIF4G is demonstrated by the finding that am-
plification of overall eIF4GI protein levels occurs in squamous
cell lung carcinoma (3) and breast carcinoma (2), while over-
expression of cDNA encoding the shortest isoform of eIF4GI
causes the malignant transformation of mammalian cell lines
(14, 22). The original cDNA clone of eIF4GI (52) was ex-
tended in a later study (23) to identify the PABP binding site.
The independent discovery of a further N-terminal extension
of 40 amino acids finally identified the longest possible open
reading frame of eIF4GI (7, 9), with these studies suggesting
alternative translation initiation can generate five isoforms of
eIF4GI. The identification of three promoters within the
eIF4GI gene locus and the finding that mRNAs from one of
these promoters are also alternately spliced (10) indicate that
there are multiple levels at which the expression of eIF4GI can
be regulated. Until recently, no evidence had been found for
differential activities between eIF4GI and eIF4GII, since the two
proteins could functionally complement each other in various
translation assays. However, an important difference has recently
been revealed with the discovery that during megakaryocytic
differentiation, eIF4GII is selectively recruited into eIF4F
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complexes (11). In addition, eIF4G homologues differ in their
phosphorylation status, with serum-stimulated sites of phos-
phorylation identified in the C terminus of eIF4GI but not in
eIF4GII (44, 46), suggesting a possible isoform-specific role for
this modification. In contrast, eIF4GII phosphorylation is in-
creased primarily at the G2/M phase of the cell cycle (44, 46),
when there is a transient decrease in overall translation rates,
although it remains unclear how these individual phosphory-
lation events modulate translation.
Since eIF4G plays such a central role in the assembly of the
preinitiation complex, it is not surprising that modifications of
eIF4GI and eIF4GII by physiological cleavage events have
drastic consequences for translation initiation (reviewed in ref-
erences 37 and 43). Cleavage of eIF4GI and eIF4GII by pi-
cornavirus proteases (leader or 2A protease) leads to the sep-
aration of the region involved in mRNA cap binding from the
ribosome binding portion of the molecule (reviewed in refer-
ence 38). This results in a severe, selective inhibition of host
protein synthesis, with the C-terminal fragment of eIF4G
functioning in a modified preinitiation complex to allow
translation of uncapped viral RNA and certain cellular
IRES-containing mRNAs (5, 25). Human immunodeficiency
virus type 1 protease-mediated cleavage of eIF4GI but not
eIF4GII has also been observed (40, 51), with both eIF4GI
and eIF4GII being targets for caspase-mediated degrada-
tion during apoptosis (37).
However, in spite of this knowledge, little is currently known
about the partner binding capacities or function of the differ-
ent isoforms and variants of eIF4G in translation initiation. To
directly address the role for the different full-length isoforms of
eIF4GI in vivo, we have used short interfering RNAs (siRNAs)
expressed from DNA vectors (49) to reduce the expression of
eIF4GI in HeLa cells (21), causing morphological changes and
a partial inhibition of translation rates. The latter could be
ascribed to a general dephosphorylation of 4E-BP1 and de-
creased eIF4F complex levels, with no change in eIF2 phos-
phorylation. Upon expression, the siRNA-resistant Myc-tagged
eIF4GI isoforms were able to form eIF4F complexes in line with
the binding sites present in the molecules. However, even though
the eIF4GIf isoform was relatively poorly expressed, it was sig-
nificantly more efficient at promoting translation than the highly
expressed, shortest isoform of eIF4GI used in previous studies.
MATERIALS AND METHODS
Plasmids expressing siRNA hairpins and eIF4G sequences. Details of oligo-
nucleotide primers used are provided in the supplemental material. In all cases,
the presence of the correct siRNA or eIF4G sequence was verified by restriction
digestion and automated sequencing. A reference plasmid for the quantitative
real-time PCR assays containing a single copy of each amplicon was created by
deleting a 3.7-kb BglII-to-SpeI fragment from pSPORT4GI (a kind gift from
Richard Lloyd) to make p4GI. Two cDNAs corresponding to the  and 
amplicons were amplified from cDNA made from total HeLa RNA with the
Improm II reverse transcription system (Promega) using random primers. The 
amplicon, amplified with primers RT alpha F and RT alpha R, and the 
amplicon, amplified with primers RT gamma F and RT gamma R, were inserted
into the BspEI and XbaI sites of p4GI, respectively. Three potential siRNA
target sites (si2, si5, and si31) were identified in the N terminus of the eIF4GI
sequence using the siRNA design tool (www.ambion.com), and corresponding
oligonucleotides were inserted into the pSilencer 3.0 H1 plasmid (Ambion). A
control siRNA that corresponded to each eIF4GI-specific siRNA was created
that contained mismatches to the center of the target site and oligonucleotides
inserted into the same vector. A plasmid to quantify the effects of siRNA-
mediated silencing of eIF4GI mRNA was created by amplifying a fragment of
the plasmid pcDNAmN-FAGf (12) with primers siCH F and 4G-N R and
inserting the XhoI-digested product into the vector psiCHECK2 digested with
the same enzyme (Promega). Renilla and firefly luciferase activities were mea-
sured using the dual-luciferase reporter assay system as per the manufacturer’s
instructions (Promega). The vector pcDNAmyc and variants containing the five
different eIF4GI open reading frames or the middle apoptotic cleavage fragment
M-FAG have been previously described (12). The QuikChange site-directed
mutagenesis method (Stratagene) and the primers si31mutF and si31mutR were
used to introduce three nucleotide changes in vectors containing eIF4GI cDNA
sequences that would maintain the correct protein sequence but prevent siRNA-
mediated degradation of the exogenous mRNA. In addition, we subcloned the
eIF4GII open reading frame encoding the previously published sequence (18) by
reverse transcription (RT)-PCR from HeLa cell mRNA using the StrataScript
One-Tube RT-PCR kit with the Easy-A PCR cloning enzyme (Stratagene) and
the primers 4GII5F, 4GII5R, 4GII3F, and 4GII3R. Following amplification,
the resultant eIF4GII 5 and 3 cDNAs were ligated into pGEM T-Easy (Pro-
mega). The cDNAs were introduced into the pcDNAmyc vector in two steps.
First, the 5 eIF4GII cDNA was inserted between the HinDIII and NotI sites of
pcDNAmyc. This vector was digested with BspEI and NotI, and the 3 eIF4GII
cDNA was inserted via the same sites.
Cell culture and transient transfection. Materials for tissue culture were from
Invitrogen (United Kingdom), and fetal calf serum was from Labtech Interna-
tional (United Kingdom). HeLa, HEK293, and MCF7 cells were obtained from
the European Collection of Cell Cultures and maintained in Dulbecco’s modified
Eagle’s medium (HeLa and HEK293) or RPMI (MCF7) supplemented with 10%
fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2. Cells
were seeded on 5-cm plates at a density of 100,000 cells per plate. Twenty-four
hours later, 1 g of pSilencer DNA and 2 g of isoform-specific pcDNAm4G or
1 g of pcDNAmM-FAG was transfected into each well using FuGene 6 (Roche,
United Kingdom), according to the manufacturer’s protocols. The transfection
mixture was removed 24 h later, and the cells were washed twice with phosphate-
buffered saline (PBS) before being incubated for a further 48 or 72 h in fresh
media.
Northern blotting and quantitative RT-PCR. Total cellular RNA was isolated
using the RNAqueous kit (Ambion) according to the manufacturer’s protocol.
Equal amounts of RNA were subjected to denaturing agarose gel electrophoresis
using the NorthernMax kit (Ambion). Prior to Northern blotting, RNA was
visualized with Radiant Red staining (Bio-Rad) and then transferred from the
gel to a Zetaprobe nitrocellulose membrane (Bio-Rad) using capillary blotting.
A random-primed, radiolabeled probe against eIF4GI was created by digesting
pcDNAmC-FAG (12) with HindIII and XhoI. The 1.3-kb fragment encoding
C-FAG was isolated and labeled with [-32P]dCTP (800 Ci/mmol) using the
RadPrime DNA labeling system (Invitrogen). Unincorporated nucleotides were
removed by passing the probe through a NucAway column (Ambion). The probe
was hybridized to the membrane overnight and, following washing, was detected
by phosphorimager analysis. A control probe against -actin was then hybridized
to the membrane and visualized in the same way. Total cDNA for the quanti-
tative PCR assay was prepared from total RNA with the Improm II reverse
transcription system (Promega) using random primers. The QuantiTect SYBR
Green PCR kit (QIAGEN) was used to detect different species of eIF4GI
mRNA or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA, using
the primers described in the supplemental material, which were designed using
Primer Express Program v2.0 (Applied Biosystems). Amplification reactions
were carried out and analyzed using an Applied Biosystems 7500 real-time PCR
system.
Preparation of cell lysates and measurement of protein synthesis rates. Cells
were harvested by scraping into ice-cold PBS containing 40 mM -glycerophos-
phate and 2 mM benzamidine. Following centrifugation for 1 min at 10,000  g,
cells were resuspended in buffer A (20 mM morpholinepropanesulfonic acid–
KOH, pH 7.4; 25 mM KCl; 2 mM MgCl2; 2 mM benzamidine; 2 mM Na3VO4;
1 M microcystin; 2 mM EGTA; 20 mM NaF; 0.1 mM GTP, 10% [vol/vol]
glycerol; 1 Complete EDTA-free protease inhibitor cocktail [Roche]) and
lysed by the addition of 0.5% (vol/vol) Igepal and 0.5% (vol/vol) deoxycholate.
Nuclei and insoluble protein were removed by centrifugation for 5 min at
10,000  g and 4°C, and the resulting supernatant was snap frozen in liquid N2.
To determine protein synthesis rates after 96 h of transfection, the conditioned
medium was supplemented with 33 Ci/ml of [35S]methionine (ICN Biomedi-
cals) for 60 min prior to harvesting cells as described above. Incorporation of
[35S]methionine into protein was determined by precipitation with trichloro-
acetic acid and scintillation counting.
m7GTP-Sepharose affinity isolation of eIF4E and associated factors. For the
isolation of eIF4E and associated proteins, cell extracts of equal protein con-
centrations were subjected to m7GTP-Sepharose chromatography (Amersham
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Biosciences, United Kingdom) and the resin washed twice with buffer B (20 mM
morpholinepropanesulfonic acid–KOH, pH 7.4, 25 mM KCl, 2 mM C4H6MgO4,
2 mM benzamidine, 2 mM 2-mercaptoethanol, 0.1 mM GTP, and 0.25% [vol/vol]
Igepal). Recovered protein was eluted directly into sample buffer.
Immunoblotting and antibodies. Cell lysates adjusted to contain equal
amounts of protein or obtained from m7GTP-Sepharose affinity isolation were
subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred to a polyvinylidene difluoride (PVDF) membrane (Am-
ersham Biosciences, United Kingdom), and proteins were visualized with the
antibodies described below. Appropriate secondary antibodies conjugated to
horseradish peroxidase were used to visualize antibody complexes with enhanced
chemiluminescence reagents (Perbio, United Kingdom). Polyclonal rabbit anti-
bodies against epitopes in the C terminus of eIF4GI (residues 1179 to 1206), the
N terminus of eIF4GI (residues 43 to 62), eIF4E (residues 203 to 217), and
PABP1 (residues 413 to 434) have been previously described (8, 12). Rabbits
were immunized with the following peptides or bacterially expressed proteins to
raise polyclonal antibodies against the N terminus of eIF4GI (residues 175 to
200; KRERKTIRIRDPNQGGKDITEEIMS), against eIF4GII (residues 183
to 419; QLP.TPP), and against eIF4A (residues 348 to 369; DLPANRENYI
HRTGRGGRFGRK). All peptide antisera were isolated from crude serum by
affinity chromatography with the corresponding peptide using the SulfoLink kit
(Perbio, United Kingdom) according to the manufacturer’s instructions. The
anti-Myc 4A6 monoclonal antibody was purchased from Upstate, and the anti-
-actin polyclonal antibody was from Sigma (United Kingdom). Polyclonal an-
tibodies to 4E-BP1, phospho-4E-BP1, total eIF2, phospho-eIF2, and phos-
pho-eIF4GI were from Cell Signaling Technology (United Kingdom). In all
cases, care was taken to ensure that detection was within the linear response of
the individual antiserum to the protein.
Immunofluorescence microscopy. HeLa cells, seeded on glass coverslips in
six-well plates and transfected as described above, were prepared for immuno-
fluorescence microscopy by fixation in 4% (wt/vol) paraformaldehyde in PBS, pH
7.4, for 15 min and permeabilized in PBS containing 0.1% (vol/vol) Triton X-100
for 8 min. Following blocking, eIF4GI was detected with the C-terminus-specific
antibody, followed by swine antirabbit immunoglobulin G conjugated to tetra-
methyl rhodamine isocyanate (Dako, United Kingdom), as previously described
(12). Actin was detected by phalloidin conjugated to fluorescein isothiocyanate
(FITC) (Sigma, United Kingdom), while nuclei were stained with 4,6-di-
amidino-2-phenylindole hydrochloride (Sigma, United Kingdom). Cells were
analyzed using a Zeiss Akioscop II microscope, as previously described (12).
Statistical analysis of data. For dual-luciferase and quantitative PCR exper-
iments, data were collected from at least three independent experiments with
assays performed in duplicate. For [35S]methionine incorporation into protein,
data were collected from two independent experiments, with each assay per-
formed in triplicate. Each chart shows the mean of these values, with error bars
representing the standard error of the mean. Unpaired two-way t tests were
performed using GraphPad Prism version 4.01 for Windows (www.graphpad.com).
RESULTS
The eIF4GI promoters are used with different efficiencies in
human cell lines. Recent work has identified three promoters
(, , and ) (Fig. 1A) in the eIF4GI gene locus, with alter-
native splicing of the first eight exons giving rise to at least
seven different mRNA species (Fig. 1B) (10). The mRNAs
transcribed from the  and  promoters encode all possible
eIF4GI proteins, whereas the single mRNA arising from the 
promoter encodes the isoform lacking the PABP-binding site
(eIF4GIa). To measure the usage of the different eIF4GI pro-
moters in different human cell lines, we have developed a
quantitative RT-PCR assay. Total mRNA was reverse tran-
scribed from three different cell lines (cervical carcinoma
[HeLa], embryonic kidney cells [HEK293], and mammary car-
cinoma [MCF7]) (Fig. 1C), and the resulting cDNAs were
amplified in the presence of the double-stranded DNA binding
dye, SYBR Green. Using a reference plasmid containing a
single copy of each amplicon in the same assay enabled the
relative abundances of the amplicons in cellular mRNA to be
determined compared to the abundance of total eIF4GI
mRNA. In all cases, controls were carried out to ensure only
spliced mRNA was being amplified and not unspliced RNA or
genomic DNA. It must be noted that in all these assays, the
total amount of mRNA quantified from the individual promot-
ers always exceeded that of the “total” eIF4GI amplicon; this
is most likely due to the additional transcripts detected not
being full-length mRNAs. Figure 1C shows that the  and 
promoters are used to transcribe around 50 to 60% of eIF4GI
mRNA, while the  promoter contributes only about 5 to 10%
in HeLa and HEK293 cells. In MCF7 cells, the  promoter
appeared to be used preferentially; however, this value always
exceeded that obtained for total eIF4GI mRNA (Fig. 1C),
possibly reflecting the presence of truncated transcripts in this
cell line.
The five isoforms of the eIF4GI protein arising through
alternative translation initiation can be detected without in
vitro proteolytic cleavage. With the discovery of the longest
possible open reading frame of eIF4GI mRNA (7, 9), five
protein variants of eIF4GI were found to exist in cells, gen-
erated by alternative translation initiation at various AUG
codons (Fig. 1D). It has been reported that IRES sequences
are present in the different eIF4GI mRNA species (9, 10, 15,
16), and it is possible that these are also being utilized in these
cell lines. Previous techniques to resolve the different variants
of eIF4GI and eIF4GII from cell extracts relied on proteases
to bifurcate eIF4GI (7, 9). However, we have been able to use
precast 4% Novex Tris-glycine gels (Invitrogen) and immuno-
blotting with specific antisera to resolve the eIF4GI isoforms
directly from cell extracts (Fig. 1E). Using the scheme desig-
nated in reference 7, the two longest isoforms (eIF4GIf and
eIF4GIe) were the most abundant in the three human cell lines
examined, with the shortest isoform being less plentiful. This
correlates with the greater amounts of transcripts from the 
and  promoters (Fig. 1B and C). Immunoblotting for eIF4GI
phosphorylated at Ser1148 (48) indicated that all the isoforms
of eIF4GI were phosphorylated to a similar extent during log-
arithmic growth in the different cell types studied.
Plasmid-derived siRNA can be used to knock down eIF4GI
mRNA and protein expression in HeLa cells. To investigate
whether the different eIF4GI isoforms have different transla-
tional activities and binding partners, we used three siRNAs to
reduce the expression of endogenous eIF4GI in HeLa cells
(Fig. 2A). To first enable the fidelity of silencing to be mea-
sured, HeLa cells were transfected with vectors expressing the
three different siRNA hairpins alongside a reporter construct
(psiCHECK-2; Promega) expressing Renilla luciferase mRNA
fused to the eIF4GI N-terminal RNA sequence. At 48 h after
transfection, a dual-luciferase assay was used to determine the
amount of Renilla luciferase in the cells relative to expression
of control firefly luciferase transcribed from the same plasmid
(Fig. 2B). These data show that transfecting HeLa cells with
vectors expressing three different siRNA hairpins that target
the 5 end of the eIF4GI mRNA caused a similar significant
(P 	 0.001) reduction in the levels of Renilla luciferase (Fig.
2B). This down-regulation of Renilla luciferase expression was
not observed with the vector backbone alone (empty), a vector
expressing a random siRNA hairpin (siNEG), or vectors
expressing siRNA hairpins containing mismatches to the
eIF4GI sequence (Fig. 2A). This eliminates the possibility of
nonspecific micro-RNA effects being responsible for changes
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FIG. 1. The three eIF4GI promoters are used with different efficiencies in HeLa cells. A. Diagrammatic representation of the eIF4GI gene locus, showing
the locations of the three promoters, designated , , and . Coding exons are shown in gray, and noncoding exons are shown in black. B. Diagrammatic
representation of the eIF4GI mRNAs showing alternative splice variants generated from the different promoters (adapted from reference 10). C. Total RNA
from the cell types shown was reverse transcribed and then amplified with primers specific to eIF4GI mRNAs. To quantify mRNAs arising from the promoter,
a primer pair that amplified only sequences containing exon 1 was created. The amplicon to quantify the mRNAs arising from the  promoter utilized a forward
primer with complementarity to the exon and a reverse primer specific for exon 3, while the  promoter activity was quantified with a primer pair that amplified
mRNAs containing exons  and 9. Finally, a forward primer specific for exon 28 and a reverse primer complementary to exon 29 were used to quantify the total
amount of eIF4GI mRNA in cells. Values obtained by quantitative RT-PCR were normalized to those obtained from an amplicon which detected all eIF4GI
mRNA. Data were collected from three independent experiments, with assays each performed in triplicate, and error bars represent the standard errors of the
means. D. Schematic representation of the eIF4GI protein. This figure shows the sites of alternative translation initiation, binding sites of other components of
the translation initiation machinery (7, 10, 36), and epitopes used to generate antisera used in these studies. Sites of cleavage by caspase-3 and the picornaviral
(L/2A) proteases are indicated. E. Equal amounts of extract from the cell types indicated were subjected to SDS-PAGE using 4% acrylamide precast gels and
proteins transferred to PVDF. The membrane was then probed with the antibodies shown to visualize the eIF4GI isoforms (indicated on the left and right of
the figure).
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in Renilla luciferase, and thus eIF4GI, levels (50). Having
shown that this effect was specific for the eIF4GI sequence, we
isolated total RNA from HeLa cells transfected for 48 h or 72 h
with either control vectors or the siRNA-expressing plasmids.
The siRNA-mediated knockdown of eIF4GI was measured by
a quantitative RT-PCR assay using the amplicon to determine
total eIF4GI mRNA levels relative to GAPDH mRNA. When
expressed as a ratio, these data show that relative to results
FIG. 2. Plasmid-derived siRNA can be used to knock down eIF4GI mRNA in HeLa cells. A. Three siRNA target sites were identified in the N
terminus of the eIF4GI sequence, and corresponding oligonucleotides (si2, si5, and si31) were inserted into the pSilencer 3.0 H1 plasmid (Ambion).
Mutated, control versions of each siRNA (si2M, si5M, and si31M) were also created that contained at least three mismatches to the center of the target
site. B. siRNAs directed against eIF4GI specifically inhibit the expression of a Renilla luciferase mRNA fused to the eIF4GI N-terminal RNA sequence
eIF4GI in the psiCHECK-2 vector. Dual-luciferase assays were performed on HeLa cell extracts prepared after 48 h of transfection, and the Renilla
luciferase activity was normalized to firefly luciferase expressed from the same plasmid. Each variable was compared with data from cells transfected with
the plasmid expressing a negative control siRNA (siNEG); , P	 0.001; n
 3, with error bars representing the standard errors of the means. C. HeLa
cells were transfected with siRNA-expressing plasmids for the times shown, and total RNA was extracted and reverse transcribed, as described. The
presence of eIF4GI or GAPDH mRNA was measured by quantitative RT-PCR. Each variable was compared as described for panel B; , P 	 0.001;
, P	 0.01; n
 3, with error bars representing the standard errors of the means. D. Total RNA from HeLa cells, transfected with the indicated plasmids
for the times shown, was subjected to denaturing agarose gel electrophoresis in the presence of formaldehyde. RNA was transferred to nitrocellulose and
then probed with a radiolabeled, single-stranded DNA specific for the C terminus of eIF4GI. The blot was subsequently reprobed with a radiolabeled
probe specific for -actin.
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with the random siRNA hairpin (siNEG), eIF4GI mRNA was
efficiently targeted in this system (Fig. 2C). This result was
further confirmed by Northern blotting using a radiolabeled
cDNA probe to the 3 end of eIF4GI (Fig. 2D, lanes 4, 6, and
8). To allow the eIF4GI protein to turn over following the
reduction in mRNA levels, cell extracts were made 72 h and
96 h after transfection. Immunoblotting using the antibody
raised against a C-terminal peptide of eIF4GI demonstrated
FIG. 3. Silencing of eIF4GI mRNA with alternative siRNAs has differing effects on eIF4GI protein expression and translation rates. A. Extracts
prepared from HeLa cells after transfection for 72 h (left panel) or 96 h (right panel) with the siRNA plasmids indicated were subjected to
SDS-PAGE, and proteins were transferred to PVDF, with eIF4GI and actin visualized by immunoblotting. un refers to untransfected cells, and
empty refers to cells transfected with the vector alone. B. Prior to the harvest after 96 h of transfection, cells were incubated with [35S]methionine
for 1 h, extracts prepared, and the incorporation of radioactive methionine into protein determined as described in the text (expressed as cpm/g
protein). , P 	 0.05; , P 	 0.01; ns, not significant, P 
 0.05; n 
 3, with error bars representing the standard errors of the means. C. Equal
amounts of extract from HeLa cells transfected for 72 h or 96 h with the indicated siRNA plasmids were resolved by SDS-PAGE using 10%
acrylamide gels (upper and lower panels) of 4% acrylamide precast gels (middle panel). eIF4GI was visualized by immunoblotting, as described,
and the migration of the different isoforms is indicated on the right. D. To determine promoter activity in cells transfected with siRNA2 and
siRNA5, total RNA was obtained from cells transfected for the times indicated and subjected to reverse transcription. Quantitative RT-PCR was
performed to amplify sequences derived from each promoter for total eIF4GI mRNA and for GAPDH mRNA. The values obtained are expressed
relative to the amounts of each amplicon present in untransfected cells (set at 100). Data were collected from three independent experiments, with
assays each performed in triplicate, and error bars represent the standard errors of the means.
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that siRNA31 was by far the most potent at reducing eIF4GI
protein (Fig. 3A). Semiquantitative densitometrical analyses of
eIF4GI expression (versus actin levels) showed that siRNA31
reduced levels of the eIF4GI protein to less than 10%  3%
(n 
 3) of that presented in the untransfected control at both
times. The efficacy of siRNA31 probably reflects the fact that it
targets all eIF4GI-encoding mRNA species (Fig. 2A).
Decreased levels of eIF4GI protein expression result in a
partial reduction in translation rates. To determine the effect
of reducing eIF4GI protein levels on translation rates, cells
were pulse-labeled with [35S]methionine as described above.
Figure 3B shows that when assayed after 96 h of transfection
with the siRNA2 and -31-expressing plasmids, there was a
significant, but incomplete, reduction in translation rates, re-
flecting a shift of ribosomes from polysomes to monosomes,
indicative of a possible disruption of the initiation of transla-
tion (T. M. Hinton et al., submitted). Similar but less potent
effects were observed at 72 h after transfection, while analysis
of the proteome of siRNA31-transfected cells showed that
there were also qualitative changes in protein synthesis at later
times (data not shown). Surprisingly, these effects were not
seen with siRNA5 (Fig. 3B), even though levels of eIF4GI
were reduced by 55%  5% (n 
 3) (Fig. 3A). Further work
was clearly required to determine why the alternative siRNAs
differed in their ability to reduce eIF4GI levels and translation
rates (see below).
The reduction in translation rates, to around 50% of that in
untransfected cells, is much lower than might be expected
considering the extent of the reduction in eIF4GI levels at 96 h
(for si2, 50%  7%; for si5, 55%  5%; for si31, 90%  3%
[n 
 3]) (Fig. 3A). However, this may reflect that ongoing
translation involving recycling of ribosomes on a single mRNA
is less dependent upon eIF4G (27, 39) or that there is a certain
threshold where the amount of eIF4GI is sufficient for trans-
lation to be maintained. Alternatively, the less-abundant iso-
form of eIF4G, eIF4GII, may be able to compensate for the
lack of eIF4GI under these conditions. To address this in more
detail, the expression of the different eIF4GI isoforms during
siRNA-mediated knockdown was examined in more depth by
electrophoresis of extracts on 4% acrylamide gels (Fig. 3C). As
expected, siRNA31, which is complementary to a sequence in
exon 10 and targets all eIF4GI mRNA species, resulted in a
reduction of all protein isoforms to a similar extent. However,
when extracts from siRNA2- or siRNA5-transfected cells were
examined, changes in the levels of different eIF4GI isoforms
were observed, especially at 96 h. As predicted, cells trans-
fected with siRNA5 (which targets exon 4) for 96 h showed a
marked decrease in the level of eIF4GIf, with reduced expres-
sion of eIF4GIe, while eIF4GIdc was maintained relative to
the other isoforms (Fig. 3C). This could in part explain why the
translation rate was maintained in cells transfected with
siRNA5, since the amount of eIF4GIe and eIF4GIdc in these
cells may be sufficient to keep total eIF4GI levels above a
critical threshold. Surprisingly, in cells transfected with siRNA2,
which targets exon 3 (Fig. 2A), we observed an increase in
protein expression of the shortest (eIF4GIa) isoform after 96 h
of transfection. Since translation was still partially inhibited
under these conditions (Fig. 3B), these data indicate that in
contrast to eIF4GIdc, eIF4GIa is less able to complement the
loss of the other eIF4GI isoforms, even when expressed at
elevated levels. To address whether this consistent finding
reflected changes in levels of mRNAs arising from the dif-
ferent eIF4GI promoters, quantitative RT-PCR was used to
measure these mRNA populations, total eIF4GI mRNA, and
GAPDH mRNA in cells transfected with siRNA2 or -5 for 72
or 96 h, and then levels were normalized to mRNA levels in
untransfected cells (set at 100; Fig. 3D). These data show that
there was a reduction in the levels of mRNA from the  and 
promoters, although by 96 h of transfection with siRNA5, the
levels of mRNA arising from the  promoter were returning to
normal. Although it was more marked in cells transfected with
siRNA5 than in those transfected with siRNA2, we consis-
tently observed an increase in transcript levels arising from
the  promoter. Since there was no concomitant increase in
eIF4GIa protein levels in the case of siRNA5 (Fig. 3C), these
data suggest the possibility of translational activation of the 
mRNA in response to siRNA2 for 96 h, possibly via the
eIF4GI IRES sequence that resides in this transcript (10, 26).
Decreased expression of eIF4GI promotes changes in other
components of the translation machinery and a reduction in
active eIF4F complexes. To determine what effect the loss of
eIF4GI had on other components of the translation initiation
machinery, equal amounts of extracts prepared from cells
transfected with siRNA2, siRNA5, or siRNA31 for 72 h or 96 h
were resolved by SDS-PAGE and proteins visualized by im-
munoblotting. A reciprocal effect on eIF4G expression has
been reported when eIF4E levels were reduced in HeLa cells
using antisense RNA (13), suggesting that there may be some
sort of coregulation of these two initiation factors. As shown in
Fig. 4A, depletion of eIF4GI with any of these siRNAs had
little impact on the total levels of PABP or eIF4A. However,
levels of eIF4GII and eIF4E were consistently reduced in cells
transfected with siRNA31 (Fig. 4A, right panel). This was not
observed with siRNA5 (Fig. 4A, middle panel), suggesting that
at least part of the lack of effect on translation rates under
these conditions may reflect a compensatory effect of eIF4GII
or the maintained presence of eIF4GIe and eIF4GIdc. While
the phosphorylation of the  subunit of eIF2 at Ser51 was not
reproducibly increased with any of the siRNAs, the phosphor-
ylation status of the inhibitory eIF4E binding protein, 4E-BP1,
showed differences in cells transfected with the different
siRNAs. Relative to control siRNAs, with siRNA2 (left panel)
and siRNA31 (right panel), immunoblotting with anti-eIF4E-
BP1 antiserum suggested that the protein was markedly de-
phosphorylated at 96 h, going from the predominantly hyper-
phosphorylated () to the hypophosphorylated () form.
These data were confirmed by using antiserum which recog-
nizes 4E-BP1 phosphorylated on Thr70 (Fig. 4A) and Ser65
(data not shown), events associated with its release from eIF4E
(17). In contrast, this was seen to a lesser extent with siRNA5
(middle panel); in conjunction with the maintained expression
of eIF4GII and eIF4Gdc, this may also impact on translation
rates in these cells (17, 36). As expected, isolation of eIF4E
and associated proteins by m7GTP-Sepharose chromatography
showed that the reduction of total eIF4GI levels also caused a
decrease in eIF4GI, PABP, and eIF4A copurified as part of the
eIF4F complex, with a concomitant increase in recovery of
4E-BP1 (Fig. 4B). This effect was observed with siRNA2 (right
panel) but was most dramatic with siRNA31 (left panel),
where levels of eIF4GI were reduced to a greater extent. These
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findings of reduced levels but not complete absence of eIF4F
correlate well with the reduced translation rates observed in
cells transfected with siRNA2 and -31 (Fig. 2A). In contrast,
with siRNA5, the association of eIF4G, PABP, and eIF4A with
eIF4E was not decreased, suggesting that eIF4F levels were
maintained. In addition, at 96 h, the binding of 4E-BP1 to
eIF4E was not increased over that observed with the control
siRNA (middle panel), consistent with a lack of effect of
siRNA5 on 4E-BP1 phosphorylation (Fig. 4A) and with the
lack of effects on translation rates in these cells (Fig. 3B).
Cells depleted of eIF4GI exhibit a multinucleated morphol-
ogy. To complement the biochemical analysis, we also wanted
to determine the effects on morphology when cells were de-
pleted of eIF4GI. Accordingly, HeLa cells were transfected
with the plasmid encoding siRNA31 for 72 h or 96 h (only half
the amount of siRNA plasmid was used here in order to be
able to distinguish transfected from untransfected cells) and
prepared for immunofluorescence microscopy as described.
eIF4GI was subsequently detected using a C-terminus-specific,
affinity-purified antibody (12). As shown in Fig. 5A and in
agreement with our previous studies (12, 33), while some
eIF4GI resides in the nucleus, the staining pattern for eIF4GI
in untransfected cells was predominantly cytoplasmic, with the
majority of eIF4GI localized to the perinuclear region. How-
ever, in those cells which had reduced levels of eIF4GI, the
staining pattern was more nuclear, possibly reflecting differen-
tial turnover rates of cytoplasmic and nuclear pools of eIF4GI.
One of the most striking phenotypes observed in some cells
depleted of eIF4GI, both with siRNA31 (Fig. 5A) and siRNA2
(data not shown), was that they were very large and often
multinucleated, possibly reflecting an uncoupling of mitosis
and cytokinesis as a consequence of reduced translation rates.
To further this work and to identify transfected cells more
efficiently, we developed an alternative siRNA expression vec-
tor which also encoded enhanced green fluorescent protein
(eGFP). The eGFP open reading frame, along with the cyto-
megalovirus promoter and simian virus 40 poly(A) signal from
the vector peGFP-N1 (Clontech, United Kingdom), were in-
serted into the pGEM T-easy vector (Promega, United King-
dom). The sequence encoding the H1 promoter, siRNA hairpin,
and termination signal from the various pSilencer plasmids was
then subcloned into this vector. Cells were then transfected for
72 h or 96 h with either of these plasmids (Fig. 5B, lanes 3, 4,
7, and 8) or the pSilencer plasmids (lanes 1, 2, 5, and 6), and
the silencing of eIF4GI and expression of eGFP were moni-
tored by immunoblotting. As shown in Fig. 5B, eGFP was
efficiently expressed from these vectors without affecting the
ability of the siRNA to reduce the level of eIF4GI. Therefore,
asynchronous, mid-log-phase HeLa cells were transfected with
these vectors and prepared for immunofluorescence micros-
copy (Fig. 5C). The difference in eIF4GI staining (red) is
clearly evident between those cells which have been trans-
fected with the plasmid (and therefore express eGFP [green])
and those which have not. Again, a number of cells depleted
for eIF4GI and contributing to the inhibition of protein syn-
thesis became enlarged and multinucleated. This vector was
also utilized in live cell imaging, where the different events
leading to multinucleation can be observed in more detail (see
the supplemental material). These data show that some cells
depleted for eIF4GI did not divide at all, possibly because they
were unable to synthesize essential proteins required for cell
cycle transition. In addition, other cells divided normally, with
daughter cells then fusing before dividing again, leading to a
multinucleated phenotype. In other examples, cells divided
into very unequal daughter cells, the smaller of which eventu-
ally underwent apoptosis, while the larger cell survived to di-
vide into three cells. These data confirm that perturbations in
protein synthesis caused by depletion of eIF4GI, below a crit-
ical threshold, had severe effects on protein synthesis, the con-
trol of cell cycle progression, and cytokinesis.
siRNA-resistant eIF4G is incorporated into eIF4F and leads
to partial restoration of translation rates. To facilitate the
expression of eIF4GI cDNAs in cells in which levels of endog-
enous eIF4GI had been reduced, the three mismatches used to
create the control siRNA (si31M) were introduced into
Myc-tagged eIF4GI cDNAs (12). This rendered them siRNA
resistant without changing the amino acid sequences of the
eIF4GI isoforms. Other cDNAs encoding the middle caspase
FIG. 4. Silencing of eIF4GI also results in reduced levels of eIF4E
and the dephosphorylation of 4E-BP1. A. Equal amounts of cell ex-
tract from HeLa cells transfected with the indicated siRNA plasmids
for 72 h or 96 h were subjected to SDS-PAGE and the indicated
proteins visualized by immunoblotting. B. Aliquots of extracts contain-
ing equal amounts of protein were subjected to m7GTP-Sepharose
affinity chromatography to recover eIF4E and associated factors. Pro-
teins were resolved by SDS-PAGE and visualized by immunoblotting
using the antisera indicated. These data are from a single experiment
but are representative of those obtained in at least three separate
experiments.
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cleavage fragment of eIF4GI (M-FAG) and eIF4GII cDNAs
(18) were expressed without any further manipulation. Plas-
mids encoding siRNA31 and the resistant Myc-tagged eIF4GI
isoforms (Fig. 6A) or eIF4GII (Fig. 6B) were cotransfected
into HeLa cells for 96 h and the levels of endogenous and
exogenous eIF4G monitored by immunoblotting. Figures 6A
and B show that endogenous eIF4GI was efficiently reduced by
siRNA31 (lane 2 versus lane 1), with the different, resistant
isoforms of eIF4GI expressed to different levels (Fig. 6A, lanes
3 to 7), without any effect on total PABP or eIF4A. In agree-
ment with previous data (Fig. 4A), 4E-BP1 was dephosphory-
lated in response to siRNA31 (lane 2 versus lane 1). When
monitored with anti-eIF4GI serum, we consistently found that
eIF4GIf (lane 3), eIF4GIe (lane 4), and eIF4GIdc (lane 5)
were expressed at levels similar to those of the endogenous
protein, while eIF4GIb (lane 6), eIF4GIa (lane 7), and MFAG
(lane 8) were expressed at much higher levels, as observed
previously (12). Although levels of eIF4E were decreased by
siRNA31, expression of eIF4GI isoforms largely prevented this
decrease (lanes 3 to 7 versus lane 2). In addition, as shown with
both antiserum to the total protein and that recognizing 4E-
BP1 phosphorylated at Thr70, expression of all isoforms of
eIF4GI (Fig. 6A, lanes 3 to 8) or eIF4GII (Fig. 6B, lane 4
versus lane 2) resulted in the phosphorylation of 4E-BP1,
albeit to differing degrees. Myc-eIF4GII was consistently ex-
pressed at levels similar to that of Myc-eIF4GIf (Fig. 6B, lane
4 versus lane 3), representing expression to a much higher level
than the endogenous protein (lane 3 versus lane 1). The in-
corporation of each of the expressed siRNA-resistant eIF4GI
proteins or eIF4GII into eIF4F complexes was also examined
by m7GTP-Sepharose chromatography (Fig. 6A and B, lower
panels). As expected, siRNA31 reduced the recovery of
eIF4GI, eIF4A, and PABP in association with eIF4E (lanes 2
versus lanes 1). Coexpression of the Myc-eIF4GI proteins (Fig.
6A, lanes 3 to 8) or eIF4GII (Fig. 6B, lanes 3 and 4) resulted
in the incorporation of eIF4G into eIF4F complexes to a level
reflecting their total level of expression (upper panel). The
recruitment of PABP into eIF4F was partially restored in cells
expressing eIF4GII (Fig. 6B, lane 4) or eIF4GI with the ability
to bind PABP (Fig. 6A, lanes 3 to 6). However, these data
clearly show that the levels of PABP and eIF4A associated to
eIF4E were not fully restored upon reintroduction of eIF4G
isoforms but were increased over the levels seen when eIF4GI
was depleted (Fig. 6A, lanes 3 to 8 versus lane 2, and Fig. 6B,
lanes 3 and 4 versus lane 2). In contrast, those cells expressing
eIF4GIa (lane 7) or M-FAG (lane 8) showed PABP levels
similar to those observed in the siRNA31-transfected cells
(lane 2). The recovery of eIF4A in the eIF4F complex was
increased in all the cells expressing Myc-eIF4GI, although for
eIF4GIa (lane 7) and M-FAG (lane 8) this was not as great as
would be predicted from their expression levels.
Translation rates were assayed in parallel by measuring the
incorporation of [35S]methionine into total protein and were
expressed relative to the rate measured in untransfected cells
(Fig. 6C). As before (Fig. 3B), siRNA31-mediated reduction of
eIF4GI levels resulted in a partial inhibition of translation that
was significantly prevented by coexpression of low levels of
eIF4GIf (Fig. 6A, lane 3 versus lane 2; P 	 0.001) but not back
to the level obtained with the siRNA31M control. eIF4GIe (lane
4) and eIF4GIb (lane 6) were as effective as eIF4GIf (lane 3) in
this response, but eIF4GIdc (lane 5) and eIF4GIa (lane 7) were
significantly less able (P 	 0.005), in spite of the latter being
expressed to relatively high levels. High levels of M-FAG (lane 8)
and eIF4GII (lane 9) were able to induce a small increase in the
rate of translation over that in the silenced cells, but not to the
level observed with eIF4If (P 	 0.05). Although there were no
obvious qualitative differences in translation assessed by SDS-
PAGE, work is currently under way to establish just how the
isoforms of eIF4GI and eIF4GII differ in their ability to recruit
different mRNAs and proteins to active translation complexes.
DISCUSSION
Mammalian eIF4GI is a family of modular proteins, consist-
ing of three domains of approximately 500 amino acids each
(as defined by proteolytic cleavage), separated by unstructured
linker regions (37, 43). eIF4GI has an important role in trans-
lation initiation, allowing multiple initiation factors to assem-
ble at the 5 cap of an mRNA molecule, thereby promoting its
recruitment by the small ribosomal subunit (reviewed in ref-
erence 37). Recent studies with Saccharomyces cerevisiae have
also suggested that eIF4G may have an undetermined but
rate-limiting function at a step downstream of 48S complex
assembly in vivo (24). In spite of this knowledge, little is known
about how the level of eIF4G is regulated at the transcriptional
and translational levels, and IRES sequences present in the
different eIF4GI mRNA species may also play a role in ex-
pression under different growth conditions (9, 10, 15, 16, 47).
To address this, we have quantified eIF4GI mRNA levels from
a number of mammalian cell lines. Figure 1C shows that the 
and  promoters are used to transcribe around 50 to 60% of
eIF4GI mRNA, while the  promoter contributes only about 5
to 10% in HeLa and HEK293 cells. We have also shown that
it is possible to resolve the eIF4GI isoforms directly from cell
extracts by using 4% Novex Tris-glycine gels and immunoblot-
ting with specific antisera (Fig. 1E). Western blotting con-
FIG. 5. HeLa cells with reduced expression of eIF4GI often show a multinucleated morphology. A. HeLa cells were grown on glass coverslips
and after transfection for 72 h (top panels) or 96 h (bottom panels) with siRNA31 were processed for immunofluorescence microscopy, as
described in the text. eIF4GI was detected with the C-terminus-specific antibody, followed by goat antirabbit immunoglobulin G conjugated to
tetramethyl rhodamine isocyanate; actin was detected with phalloidin conjugated to FITC, while nuclei were stained with 4,6-diamidino-2-
phenylindole hydrochloride. These data are from a single experiment but are representative of those obtained in at least five separate experiments.
B. HeLa cells were transfected with siRNA31 expression vectors (lanes 1, 2, 5, and 6) or siRNA31-eGFP vectors (lane 3, 4, 7, and 8) for the times
indicated. Extracts were prepared, and eIF4GI, actin, and eGFP expression was monitored by SDS-PAGE and immunoblotting, as indicated. C.
HeLa cells were grown on glass coverslips and after transfection for 96 h with siRNA31-eGFP (upper panels) or siRNA31M-eGFP (lower panels)
were processed for immunofluorescence microscopy, as described for panel A. These data are from a single experiment but are representative of
those obtained in at least three separate experiments.
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firmed that we can resolve five isoforms of eIF4GI and that,
consistent with data from K562 cells (7), eIF4GIf and eIF4GIe
are the most abundant in the human lines tested (Fig. 1E). This
correlated with the greater amounts of transcripts from the 
and  promoters (Fig. 1B and C). Surprisingly, we found that
transcript levels arising from the  promoter increased in re-
sponse to siRNA-mediated reduction of mRNA expression
from the  and  promoters (Fig. 3D). Since a concomitant
increase in the eIF4GIa protein level (Fig. 3C) was seen with
the siRNA targeting mRNAs i to vi (Fig. 2A), these data
suggest that translational activation of the  mRNA occurs at
later incubation times, possibly via the eIF4GI IRES sequence
that resides in this transcript. Further work is under way to
determine whether reduced mRNA expression from the  and
 promoters occurs during mitosis, thereby explaining why
eIF4GI mRNA is retained in polysomes under conditions of
reduced cap-dependent translation (26, 47).
Apart from the presence of the PABP binding site (23, 42),
little is known about the poorly conserved N-terminal domain
differentially expressed in the eIF4GI isoforms (Fig. 1D) or
how it might influence the function of the protein. The shortest
isoform (designated eIF4GIa, also the first cloned [52]) lacks
the sequence that interacts with PABP (Fig. 1D) but is still
capable of transforming cells when overexpressed (14, 22). The
eIF4E binding domain and central region are highly conserved,
being essential for cap-dependent translation (35). The former
undergoes a disordered-to-ordered transition when it binds
eIF4E (20, 31), while the central domain shows a defined
globular structure consisting of five HEAT repeats (31). The
C-terminal region, which is restricted to higher eukaryotes, has
recently been shown to contain two atypical HEAT domains
(4) and appears to modulate translation driven by the central
domain (35). Most in vivo experiments to determine the role
for various isoforms or cleavage fragments of eIF4GI have
been carried out in a background of endogenous eIF4GI ex-
pression (37). Here we have begun to address the possible
roles for the individual isoforms of eIF4GI in promoting trans-
lation initiation by using siRNAs to specifically inhibit its ex-
pression. Data presented in Fig. 2 and 3 show that eIF4GI
mRNA was efficiently targeted, that siRNA31 was by far the
most potent at reducing eIF4GI protein levels at 72 or 96 h
after transfection, and that this resulted in a significant but
incomplete reduction in translation rates. With siRNA31, the
50% decrease in the translation rate was much lower than
expected considering the extent of the reduction in eIF4GI
(Fig. 3A), the dephosphorylation of 4E-BP1 (Fig. 4A), and the
decrease in eIF4F levels (Fig. 4B). Although it could not be
ascribed to changes in eIF2 phosphorylation (Fig. 4A), the
incomplete inhibition could reflect that only a population of
the cells was transfected under these conditions. In addition, it
could also reflect that ongoing translation involving recycling
FIG. 6. Low levels of eIF4GIf are more efficient than high levels of
eIF4GIa at partial restoration of translation rates following reduced
expression of endogenous eIF4GI. A (upper). HeLa cells were co-
transfected for 96 h with siRNA vectors and plasmids expressing dif-
ferent Myc-tagged isoforms of eIF4GI or the apoptotic cleavage frag-
ment of eIF4G (M-FAG), as indicated. Cell extracts were prepared
and aliquots containing equal amounts of total protein resolved by
SDS-PAGE using 10% acrylamide gels or 4% acrylamide precast gels,
as indicated. eIF4GI was visualized by immunoblotting using either
anti-Myc antibody or anti-eIF4GI antiserum, and other proteins were
visualized using the antisera indicated. (Lower) Aliquots of extracts
containing equal amounts of protein were subjected to m7GTP-Sepha-
rose affinity chromatography to recover eIF4E and associated factors.
Proteins were resolved by SDS-PAGE and visualized by immunoblot-
ting using the antisera indicated. B (upper). HeLa cells were cotrans-
fected for 96 h with siRNA vectors and plasmids expressing Myc-
eIF4GII, as indicated. Extracts were prepared and proteins visualized
as for panel A. (Lower) Aliquots of extracts containing equal amounts
of protein were subjected to m7GTP-Sepharose affinity chromatogra-
phy to recover eIF4E and associated factors, as described above. C.
Prior to the harvest after 96 h of transfection, cells were incubated with
[35S]methionine for 1 h, extracts prepared, and the incorporation of
radioactive methionine into protein determined as described in the
text (expressed as cpm/g total protein). Unpaired two-way t tests were
performed separately, comparing eIF4GIf with si31 (***, P 	 0.001;
n 
 3) and comparing eIF4GIf with other isoforms of eIF4GI (*, P 	
0.05; **, P 	 0.01; ns, P 
 0.05; n 
 3), with error bars representing
standard errors of the means.
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of ribosomes on a single mRNA is less dependent upon intact
eIF4G (27, 39). A recent study has shown that translation
compartmentalized to the endoplasmic reticulum (ER) is re-
sistant to cleavage of eIF4GI by Coxsackie B virus (29), raising
the possibility that ongoing translation is maintained on the
ER in siRNA31-treated cells, although staining of eIF4GI in
the siRNA31-transfected cells does not reveal a pattern con-
sistent with ER staining. Alternatively, it may be that there is
a threshold where the amount of eIF4GI is sufficient for trans-
lation to be maintained or that the less-abundant isoform of
eIF4G, eIF4GII, can compensate for eIF4GI under these con-
ditions. While eIF4GIa levels were increased with siRNA2
treatment at 96 h (Fig. 3C), it is unlikely to be masking an
effect on down-regulating translation, since a similar level of
inhibition was observed with siRNA31, which had no effect on
eIF4GIa levels (Fig. 3B).
In all cases, the failure to rescue translation to the control
level may reflect that we are examining a mixed cell popula-
tion. For instance, as shown in Fig. 5 (and reference (12), some
cells express high levels of Myc-eIF4GI, others lower levels,
and others none at all, but with analysis by SDS-PAGE, we
observed a reasonable, overall expression. It is also possible
that not all silenced cells were cotransfected with the siRNA-
resistant eIF4G cDNAs. We are currently attempting to ad-
dress this by studying the rescue of translation in eGFP-posi-
tive cells sorted by fluorescence-activated cell sorting. Due to
the phenotype associated with reduced expression of eIF4GI
(Fig. 5), we have not been able to generate viable, stable cell
lines, but attempts will be made to generate stable cell lines to
allow for inducible expression of siRNAs. Another explanation
could be that replacement of endogenous eIF4GI with just a
single isoform was insufficient to fully recover translation rates.
However, coexpression of eIF4GIf and eIF4GIe was insuffi-
cient to rescue translation rates above that seen with the indi-
vidual isoforms (data not shown).
Figure 6A shows that even though the eIF4GIf isoform was
the least abundantly expressed, it was relatively more efficient
at restoring overall translation rates than the eIF4GII or
eIF4GI isoform, which was expressed to higher levels (Fig. 6A
to C). Even though the shorter, eIF4GIa isoform was ex-
pressed to the highest level and was incorporated efficiently
into eIF4F complexes, we consistently found that possession
of an N-terminal extension rendered eIF4GIe and eIF4GIb
statistically more efficient at rescuing translation rates than
eIF4GIa. Similarly, overexpression of M-FAG, the minimum
fragment of eIF4GI able to participate in in vitro cap-depen-
dent translation (35) and which binds to eIF4E, eIF4A, and
eIF3, was unable to rescue translation to the same extent as the
longest isoforms of eIF4GI, possibly reflecting the poorer in-
corporation of eIF4A into eIF4F complexes in these cells. The
effects of reintroduction of eIF4GI cDNAs lacking partner
binding sites on general protein synthesis have also been tested
(Hinton et al., submitted). These data suggest that the PABP
interaction site is not required for the rescue of translation,
suggesting a novel function for the N-terminal extension of
eIF4GI. Using the techniques developed in this study, we are
currently in the process of characterizing proteins which inter-
act with this sequence and attempting to further delineate
eIF4G isoform-specific effects on cap-dependent and cap-in-
dependent mRNA translation using microarray analysis of
polysome-associated mRNAs.
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